Quick Answer: Private label cosmetics for Japan need a controlled agreement between the brand, contract manufacturer and Japanese marketing authorization holder (MAH). Confirm classification and the local operating arrangement, provide reviewable formula and quality records, approve Japanese artwork and assign batch release, complaint and change responsibilities before commercial supply. Buying a ready-made formula or owning the trademark does not itself establish Japanese regulatory readiness.
Start with a private label project brief
A private label project can begin with an existing manufacturer formula, a modified stock base or a bespoke development. These options create different questions about ownership, access and future supply. Record the exact product, intended use, application area, pack, claims and formula revision before comparing quotations. A price for a generic cream is not a specification for the Japanese SKU you intend to sell.
State whether the brand expects exclusivity, ownership of development results, access to quantitative composition or a right to transfer production. These are negotiated commercial terms, not automatic consequences of paying for tooling or placing an order. Define territories, product scope, duration and permitted use of confidential records. Make the agreement clear enough that a new colleague can identify what the brand actually controls.
Agree who supplies Japanese technical review and who can stop the project when a requirement remains unresolved. This guide focuses on the manufacturing and ownership handoff. For channel selection and launch economics, use our Japan cosmetics market entry guide alongside the product file.
| Role | Project contribution | Question to settle in writing |
|---|---|---|
| Brand owner | Product brief, trademark, claims and artwork decisions | Which records and development rights does it control? |
| Contract manufacturer | Formula, production, specifications and investigation support | What can be disclosed and to whom? |
| Japanese MAH | Local assessment and responsible market operations | Which entity holds the applicable licence and duties? |
| Importer and logistics partners | Consignment handling and traceability | Who handles each operation and release condition? |
Identify the Japanese responsible operator early
The Japanese PMD Act establishes distinct marketing and manufacturing business licensing arrangements. Verify the actual Japanese entity and relevant operating scope with a competent local specialist. A distribution contract, customs service or brand licence does not by itself answer who performs the regulated role. Keep documentary checks separate from assumptions based on a partner’s sales experience.
Ask the proposed MAH how it receives confidential formula data, reviews supplier changes, handles complaints and coordinates decisions with an overseas factory. Establish named contacts, backups and an escalation route. A contact list should identify who decides, who investigates and who communicates, rather than giving every task to a general sales inbox.
Discuss the end of the relationship at the beginning. Agree access to historical records, treatment of remaining stock and support for a replacement local partner. A business transition can affect product identity, labels and procedures. Have the local reviewer determine what is required before the new arrangement supplies goods.
Resolve classification before using a stock formula
A manufacturer’s catalogue may describe a product as whitening, medicated or therapeutic for another market. Review the actual Japanese presentation before adopting that wording. Read the product name, directions, formula and proposed claims together. Our cosmetics versus quasi-drugs guide provides a starting point for that discussion; an ambiguous product needs a qualified local decision.
PMDA’s cosmetics FAQ states that cosmetics must comply with the Standards for Cosmetics and generally do not require a product marketing approval application. This does not make a supplier’s stock formula a product approval, nor does it resolve the business arrangements or applicable notifications. Ask the MAH to confirm the procedure for the exact product and supply case.
Document the agreed cosmetic purpose in the brief and carry it through sample evaluation, packaging and online copy. If the brand later asks for a stronger claim, reopen the classification discussion before approving it. No manufacturer certification should be described as a Japanese quasi-drug approval unless the specific evidence and scope have been verified.
| Model | Useful advantage | Handoff issue |
|---|---|---|
| Existing stock formula | Established manufacturing experience | Obtain enough disclosure for the Japanese assessment |
| Modified base | Targeted sensory or pack adjustment | Identify which earlier evidence still applies |
| Custom development | Product designed around the brief | Define results, rights and transfer support |
| Second source proposal | Potential supply continuity | Reassess the actual formula, process, site and evidence |
Build a formula disclosure route that works
Agree a secure route for the complete quantitative composition to reach the authorised Japanese reviewer. The factory may wish to protect know-how, but the reviewer needs sufficient information to make the relevant decisions. Use a confidentiality arrangement and controlled recipients rather than substituting a marketing ingredient list for the technical formula.
Separate trade names from constituent identity. Premixes, fragrance systems, botanical extracts and supplied solutions can introduce additional substances. Record the formula revision, raw-material versions and relevant supplier information so the assessment can be connected to what production will actually use. Keep a log of open questions and their resolution.
The MHLW Standards for Cosmetics contain general safety provisions and substance restrictions, with specific controls for preservatives, ultraviolet absorbers and tar colours. Apply them to the actual intended product. Our Japanese ingredient requirements guide explains the formula review workflow in more depth. A formula accepted for another destination still needs its own Japanese assessment.
Ask the factory to identify what changes it may make without notice under its usual supply terms. An apparently equivalent raw material can change constituent composition, impurities or supporting evidence. Replace vague substitution rights with a clear review process for the Japan project.
Agree the evidence package before the production order
Prepare a document index with an owner, revision and delivery date for each item. Include product and raw-material specifications, the controlled composition, relevant quality and safety information, manufacturing site details, packaging specifications and available stability or compatibility results. Distinguish completed reports from plans and supplier summaries.
Testing should follow the product and identified risks. Discuss microbiological quality, preservation, stability and interaction with the selected pack where relevant. A report from the stock base may inform the discussion, but changes in fragrance, preservation, viscosity, filling process or packaging can limit its applicability. Record the reviewer’s conclusion rather than treating a familiar report title as sufficient evidence.
Agree the handling of retained samples, batch coding, deviations and out-of-specification results. Specify which information accompanies each batch and which remains retrievable at the factory. A certificate of analysis is more useful when its tests and acceptance limits match the agreed finished-product specification.
Use the OEM/ODM manufacturing project brief to organise a detailed request. Identify gaps early enough to affect the schedule and quotation. Commercial agreement on a minimum order quantity should follow a clear view of the development, evidence and packaging work still needed.
Control artwork as a product record
Create a single copy master linked to the approved product and formula. Have the Japanese reviewer confirm mandatory particulars, product naming, ingredient names, directions and precautions for the actual pack. The Tokyo government cosmetics labelling guidance explains information required on direct containers and the outer-pack implications when it is not readily visible. It also addresses Japanese ingredient names and premix constituents.
Keep ownership of artwork files distinct from authority to approve the copy. The brand may own the design while the Japanese operator needs to approve local particulars. Establish who releases the final proof to the printer, how obsolete files are withdrawn and which proof the filling line uses.
Check the bottle, carton and any supplementary label at actual size. Review joined Japanese sentences and the overall claim impression, not isolated translated text units. Approve product listings and promotional copy against the same claim master. An attractive front panel can undermine the project if it suggests a different product purpose from the reviewed brief.
| Gate | Required record | Decision before proceeding |
|---|---|---|
| Development lock | Product brief and formula revision | Local assessment questions are closed |
| Evidence review | Document index and relevant reports | Remaining work is understood and assigned |
| Print release | Approved copy master and pack proof | Correct production artwork is authorised |
| Batch release | Quality records and reconciled packaging | Held discrepancies are resolved |
| Reorder | Change review and market feedback | Current specification remains supported |
Make release and complaints practical
Define a release checklist that connects manufacturing records with the product destined for Japan. Confirm batch identity, specification results, approved packaging and transport conditions. Separate factory release, import handling and the local decision to supply. Assign who holds stock when an unresolved discrepancy is found and how the hold is communicated.
Create a complaint route that preserves product identity, batch number, use details and available photographs or samples. The brand should route information promptly to the Japanese responsible team and factory contacts. Agree investigation support and decision authority for corrective action. A customer-service refund alone does not complete the technical investigation.
Work through an example before launch: a retailer reports leaking pumps from one delivery. Identify who checks affected batches, retrieves compatibility records, compares retained samples and determines the stock action. The exercise often exposes gaps that remain hidden in a contract containing only general promises of quality.
Preserve continuity through changes and exits
Use a written change request for formula, raw-material supplier, manufacturing site, process, packaging, artwork and claims. Describe the proposed change, reason, affected records and batches, evidence impact and intended implementation date. The Japanese reviewer should assess local implications before changed goods enter the agreed supply route.
Plan a supplier exit package appropriate to the negotiated rights. It may include current specifications, approved artwork, tooling information, accessible reports and cooperation with the incoming reviewer. Do not assume a right to transfer a proprietary formula. Equally, do not discover at the first supply interruption that essential compliance records exist only in an inaccessible email account.
For a Japan private label brief, contact the project team with the product type, development model, proposed MAH, intended claims and document gaps. Ask for a defined manufacturing deliverable list and an accountable schedule. Product-specific Japanese decisions should remain with qualified reviewers and the responsible local operators.
| Change | Potential consequence | Record to reopen |
|---|---|---|
| Fragrance or premix supplier | Different constituents or quality information | Formula assessment and relevant testing |
| Container or pump | Different compatibility or delivery performance | Pack specification and supporting evidence |
| Japanese commercial partner | Different responsible operator information | Local procedure, artwork and transition plan |
| Benefit claim | Different consumer interpretation or classification | Claim support and product brief |
Frequently asked questions
Does owning a private label brand make it the Japanese MAH?
No. Trademark ownership and the Japanese licensed operating role are separate questions. Verify the actual entity and responsibilities for the proposed supply arrangement.
Can the manufacturer keep the formula confidential?
Commercial confidentiality can be protected through controlled disclosure and agreements. The authorised reviewer still needs sufficient information for the Japanese assessment; agree that route before ordering.
Can I use an unchanged stock formula for Japan?
Only after reviewing the exact composition, intended use, claims, evidence and local requirements. Previous sale elsewhere does not establish Japanese readiness.
Who should approve Japanese artwork?
Agree the brand’s design approval and the competent local compliance approval in writing. Release one controlled proof tied to the formula, product identity and responsible operator.
What should happen before a supplier substitution?
Evaluate the actual change, constituent and evidence impact, affected batches and Japanese implications. Document the approval and implementation point before changed goods are supplied.
Last reviewed: 26 October 2026. General manufacturing and project planning information only, not product-specific legal or safety advice. Confirm current Japanese requirements, procedures and applicable effective dates with a qualified Japanese reviewer before manufacture, import or sale.